Evidence map›Paper›PMID 31366955›Full record

ArticleScientific reports2019

Characterization of phenolic compounds from Eugenia supra-axillaris leaf extract using HPLC-PDA-MS/MS and its antioxidant, anti-inflammatory, antipyretic and pain killing activities in vivo.

Nesrine M Hegazi, Mansour Sobeh, Samar Rezq, Mohamed A El-Raey, Malak Dmirieh, Assem M El-Shazly, Mona F Mahmoud, Michael Wink

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Piquiá Shells (Oxidative medicine and cellular longevity · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Nesrine M HegaziDepartment of Phytochemistry and Plant Systematics, Division of Pharmaceutical Industries, National Research Center, Dokki, Cairo, Egypt.
Mansour SobehInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany. sobeh@uni-heidelberg.de.ORCID http://orcid.org/0000-0002-2719-8534
Samar RezqDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.ORCID http://orcid.org/0000-0003-4421-0686
Mohamed A El-RaeyDepartment of Phytochemistry and Plant Systematics, Division of Pharmaceutical Industries, National Research Center, Dokki, Cairo, Egypt.
Malak DmiriehInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany.
Assem M El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Mona F MahmoudDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
Michael WinkInstitute of Pharmacy and Molecular Biotechnology, Heidelberg University, Heidelberg, Germany. wink@uni-heidelberg.de.
Heidelberg University · DEZagazig University · EGNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reactive oxygen species (ROS) are involved in the pathophysiology of several health disorders, among others inflammation. Polyphenols may modulate ROS related disorders. In this work, thirty-two phenolic compounds were tentatively identified in a leaf extract from Eugenia supra-axillaris Spring. ex Mart. using HPLC-MS/MS, five of which were also individually isolated and identified. The extract displayed a substantial in vitro antioxidant potential and was capable of decreasing ROS production and hsp-16.2 expression under oxidative stress conditions in vivo in the Caenorhabditis elegans model. Also, the extract showed higher inhibitory selectivity towards COX-2 than COX-1 in vitro with higher selectivity towards COX-2 than that of diclofenac. The extract also exhibited anti-inflammatory properties: It attenuated the edema thickness in a dose dependent fashion in carrageenan-induced hind-paw odema in rats. In addition, the extract reduced the carrageenan-induced leukocyte migration into the peritoneal cavity at the highest dose. Furthermore, the extract showed antipyretic and analgesic activities in a mouse model. Eugenia supra-axillaris appears to be a promising candidate in treating inflammation, pain and related oxidative stress diseases.

Indexed as

AnalgesicsAnimalsAnti-Inflammatory AgentsAntioxidantsAntipyreticsChromatography, High Pressure LiquidEdemaEugeniaInflammationMaleMiceOxidative StressPainPhenolsPlant ExtractsPlant LeavesAnalgesicsAnti-Inflammatory AgentsAntioxidantsAntipyreticsPhenolsPlant ExtractsReactive Oxygen Species

Identifiers

PMID31366955
PMCPMC6668444
OpenAlexW2965443052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.